StockData
Neurocrine Biosciences Inc logo

Neurocrine Biosciences Inc (NBIX) bonds

NBIXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/306% below fair value
$165.92+0.61 (+0.37%)

Close on Nov 17, 2026Market cap $16.87BP/E 24.3Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Neurocrine Biosciences reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Neurocrine Biosciences's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issued
2.25% Convertible Senior Notes Due 2024
Convertible
2.25%$517.50M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeAvailableDrawn
2026 Credit Facility$1.00B$1.00B$0

See a number that looks wrong?